Summary
The product Testosterone Enanthate 300 mg/ml, manufactured by ACE Pharmaceutical Solutions, underwent independent testing to verify its authenticity and potency. The sample, identified by batch expiration date 12/2029, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.
The analysis measured the presence of Testosterone Enanthate, with a concentration of 303.23 mg/ml, exceeding the labeled claim of 300 mg/ml by 1.08%.
The testing process began on 2 May 2024, with the sample received on 7 May 2024, and analysis completed on 10 May 2024. While the results confirm accurate dosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. Manufacturer may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: ACE Pharmaceutical Solutions
- Product Name: Testosterone Enanthate 300 mg/ml
- Active Ingredient: Testosterone Enanthate
- Batch Expiration Date: 12/2029
- Expiration Date: 12/2029
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #41896
- Testing Ordered: 2 May 2024
- Sample Received: 7 May 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ACE Pharmaceuticals (Manufacturer)
- Analysis Paid For By: ACE Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 300 mg/ml (as stated on the label)
- Measured Concentration: 303.23 mg/ml
- Accuracy: 101.08% (1.08% above the label claim)
- Variance: 1.08%
Verification Details
- Verification URL: https://janoshik.com/tests/41896_6QJEV1SUIG37
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding potentially by a the Manufacturer. Manufacturer often select optimal batches for testing, which may not fully represent the consistency of products available to consumers.
While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Testosterone Enanthate 300 mg/ml is slightly overdosed, with a measured concentration of 303.23 mg/ml. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line.
This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
